ASTCAstrotech Corp

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Thomas B. Pickens

Location

Texas, USA

Exchange

Nasdaq

Website

https://astrotechcorp.com

Summary

Astrotech Corporation operates as a science and technology development and commercialization company worldwide.

Company Info

CEO

Thomas B. Pickens

Location

Texas, USA

Exchange

Nasdaq

Website

https://astrotechcorp.com

Summary

Astrotech Corporation operates as a science and technology development and commercialization company worldwide.

AI Insights for ASTC
5 min read

Quick Summary

Astrotech Corporation is a very small Austin, Texas-based science and technology commercialization company focused on analytical instrumentation, especially mass spectrometry platforms. The company operates through businesses including 1st Detect Corporation and AgLAB Inc., which develop and commercialize detection and analysis technologies. Its products are aimed at customers that need high-sensitivity chemical detection, including security operators, law-enforcement-related screening users, agricultural processors, industrial operators, and potentially healthcare or public health customers if regulatory approvals are obtained. The company has only about 10 employees, which makes it more like a development-stage commercialization business than a mature industrial equipment company. Its financial profile shows limited revenue, negative net income, and significant operating losses, so the investment case depends heavily on whether its technology can gain commercial adoption.

Strengths

•

Astrotech’s main strength is its focus on mass spectrometry technology, which can provide highly specific chemical detection.

•

The company has multiple potential application areas, including narcotics detection, threat screening, agriculture, industrial analysis, and health-related breath testing.

•

Its first deployment of the TRACER 1000 NTD in Vietnam shows that the technology is moving beyond pure development into commercial use.

•

The company’s small size may allow management to focus resources on targeted niches rather than maintaining a broad corporate structure.

•

If its systems deliver low false alarms, broad detection libraries, and practical field usability, Astrotech could win specialized customers despite competing with larger firms.

Key Risks

•

Astrotech faces high commercial execution risk because early product deployments do not guarantee broad market adoption.

•

The company’s losses and limited revenue create financing risk, especially if it needs additional capital before achieving meaningful sales scale.

•

Regulatory risk is important for any health-related product, and the company has noted risks around FDA approval for BreathTest-1000.

•

Competitive risk is also significant because larger security and analytical-instrument companies have stronger customer relationships, service networks, and financial resources.

What to Watch

During the most recent reported period, Astrotech remained a small revenue company with substantial operating losses.
The reported fundamentals show total revenue of about $913,000, gross profit of about $217,000, and total operating income of about negative $14.1 million.
A notable corporate event was the announcement that CEO Thomas B.
Pickens III was appointed CTO, formalizing his role in advancing the company’s mass spectrometry technology.
Recent news also highlighted the first sale and deployment of the TRACER 1000 NTD narcotics trace detector in Vietnam through subsidiary 1st Detect.
These events suggest the quarter’s narrative centered on technology leadership, early commercialization, and international deployment rather than near-term profitability.

Price Drivers

•

Astrotech’s stock price is likely driven more by commercialization milestones and speculative interest than by traditional earnings strength.

•

The company has very low revenue of about $913,000, negative net income of about $14.4 million, and negative EPS, so investors are not valuing it on current profitability.

•

Product deployment news, such as the first TRACER 1000 NTD sale in Vietnam, can have an outsized effect because the company’s market capitalization is small.

•

The stock’s high beta of 4.891 and wide 52-week range indicate that sentiment, liquidity, and speculative trading can strongly influence price movements.

•

Broader interest in space, defense, security, and advanced detection technologies may also affect the stock, although some recent space-related news appears to concern AST SpaceMobile rather than Astrotech.

Recent News

•

Recent company-specific news included Astrotech’s announcement of the first sale and deployment of its TRACER 1000 NTD narcotics trace detector in Vietnam.

•

The deployment was made through subsidiary 1st Detect and represents an expansion of Astrotech’s presence in Southeast Asia.

•

The system is described as using mass spectrometry to help security operators detect narcotics and other threats with high accuracy, broad library support, and near-zero false alarms.

•

Astrotech also announced that CEO Thomas B.

•

Pickens III was appointed CTO, formalizing his role in advancing the company’s mass spectrometry technology.

•

Several other recent headlines in the provided news set refer to AST SpaceMobile or general space-market speculation and should not be treated as direct news about Astrotech Corporation.

Market Trends

•

Astrotech is affected by broader demand for security screening, narcotics detection, and advanced chemical-analysis tools.

•

Governments, airports, cargo operators, and border-security agencies continue to need better detection systems as drug trafficking and security threats evolve.

•

Analytical instrumentation markets are also benefiting from demand for faster, more automated, and more application-specific testing across industrial and agricultural settings.

•

At the same time, customers in these markets often have long procurement cycles, strict validation requirements, and a preference for established vendors.

•

In the stock market, microcap technology companies with speculative commercialization stories can experience sharp price swings, especially when news, social media attention, or thematic interest in space and advanced technology increases.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on ASTC

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show